We are live on ! Find out more
GYRE icon

Gyre Therapeutics
GYRE

78 hedge funds and large institutions have $56.5M invested in Gyre Therapeutics in 2020 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 33 increasing their positions, 20 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

7,625% more call options, than puts

Call options by funds: $309K | Put options by funds: $4K

65% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 20

0.1% more ownership

Funds ownership: 8.42% → 8.52% (+0.1%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

1% less funds holding

Funds holding: 79 → 78 (-1)

10% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 10

31% less capital invested

Capital invested by funds: $81.8M → $56.5M (-$25.2M)

Holders
78
Holders Change
-1
Holders Change %
-1.27%
% of All Funds
1.57%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
9
Increased
33
Reduced
20
Closed
10
Calls
$309K
Puts
$4K
Net Calls
+$305K
Net Calls Change
-$26K

Top Buyers

1
SCM
Stonepine Capital Management
Oregon
+$4.51M
2
BlackRock
BlackRock
New York
+$994K
3
Renaissance Technologies
Renaissance Technologies
New York
+$878K
4
Goldman Sachs
Goldman Sachs
New York
+$546K
5
PM
Prosight Management
Texas
+$280K

Top Sellers

1
Citadel Advisors
Citadel Advisors
Florida
-$2M
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$1.28M
3
CCM
CAAS Capital Management
New York
-$1.05M
4
Millennium Management
Millennium Management
New York
-$1.01M
5
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$888K
Name Holding Trade Value Shares
Change 		Change in
Stake
AIM
51
Alambic Investment Management
California
$76K +$92.2K +2,357 New
New York State Common Retirement Fund
52
New York State Common Retirement Fund
New York
$69K – – –
RJT
53
Raymond James Trust
Florida
$60K +$73.1K +1,867 New
CCM
54
Colorado Capital Management
Colorado
$59K – – –
SSA
55
Schonfeld Strategic Advisors
New York
$58K -$384K -9,819 -85%
AIG
56
American International Group
New York
$57K +$13.2K +338 +24%
PAM
57
Panagora Asset Management
Massachusetts
$56K +$1.68K +43 +3%
WG
58
Winton Group
United Kingdom
$55K +$66.9K +1,710 New
EGM
59
Engineers Gate Manager
New York
$54K -$35.5K -906 -35%
Ameriprise
60
Ameriprise
Minnesota
$54K +$6.22K +159 +11%
Deutsche Bank
61
Deutsche Bank
Germany
$53K -$4.78K -122 -7%
SI
62
Stephens Inc
Arkansas
$53K +$64.7K +1,653 New
Ohio Public Employees Retirement System (OPERS)
63
Ohio Public Employees Retirement System (OPERS)
Ohio
$40K – – –
MAM
64
Marquette Asset Management
Minnesota
$28K – – –
CG
65
Cutler Group
California
$23K – – –
BNP Paribas Financial Markets
66
BNP Paribas Financial Markets
France
$21.2K +$22.3K +570 +655%
Morgan Stanley
67
Morgan Stanley
New York
$16K -$71.2K -1,818 -78%
Russell Investments Group
68
Russell Investments Group
United Kingdom
$13K – – –
Legal & General Group
69
Legal & General Group
United Kingdom
$9K -$704 -18 -6%
AIP
70
Ameritas Investment Partners
Nebraska
$7K – – –
Citigroup
71
Citigroup
New York
$5K -$6.46K -165 -54%
Bank of Montreal
72
Bank of Montreal
Ontario, Canada
$5K -$3.48K -89 -40%
Millennium Management
73
Millennium Management
New York
$4.08K -$1.01M -25,787 -17%
CAGAS
74
Capital Advisory Group Advisory Services
Minnesota
$4K – – –
BCA
75
Berman Capital Advisors
Georgia
$3K +$4.19K +107 New
1 2
3
4

GYRE Hedge Fund Activity: Q3 2020 in Review

78 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Gyre Therapeutics (GYRE) for Q3 2020, worth a combined $56.5M — down 31% from $81.8M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of GYRE and 9 opened new positions — a net loss of 1 holder — while 20 trimmed existing stakes and 33 added.

The largest buyer was Stonepine Capital Management, adding an estimated $4.51M. The largest seller was Citadel Advisors, cutting an estimated $2M.

  • 78 institutional investors held Gyre Therapeutics (GYRE) as of Q3 2020, down from 79 in Q2 2020.
  • Funds reported $56.5M of Gyre Therapeutics stock for Q3 2020, down 31% quarter-over-quarter.
  • 9 funds opened new Gyre Therapeutics positions in Q3 2020 and 10 closed out, a net change of -1 holder.
  • The largest Gyre Therapeutics buyer in Q3 2020 was Stonepine Capital Management, an estimated $4.51M added.
  • The largest Gyre Therapeutics seller in Q3 2020 was Citadel Advisors, an estimated $2M sold.

Based on aggregated 13F filings for Q3 2020.